McLaren Health Care Names New Chief Medical Officer; McLaren Health Care has selected Michael McKenna, M.D., as chief medical officer to help manage key functions, including the creation, measurement and oversight of initiatives that enhance and integrate clinical quality, ensure patient safety and satisfaction, and promote physician engagement. In collaboration with other clinical and administrative leaders at McLaren Health Care, Dr. McKenna will provide clinical guidance and input that will inform systemwide strategic-planning processes. More specifically, he will recommend, develop and supervise the implementation of objectives, plans and policies designed to improve clinical outcomes, integrate clinical care, promote the practice of evidence-based medicine, and establish a single standard of care across the McLaren system. In addition to these duties, he will work to institute and ensure best practices and oversee physician engagement initiatives. Prior to joining McLaren, Dr. McKenna served as vice president, medical management, at Advocate Lutheran General Hospital and Lutheran General Children’s Hospital in Park Ridge, Ill., affiliates of Advocate Health Care, named among the nation’s top-five largest health systems based on quality by Truven Analytics, and the largest health system in Illinois. With Dr. McKenna’s contributions, Advocate Lutheran General Hospital earned a No. 1 ranking in physician satisfaction and appeared on the Truven Health Analytics list of 100 Top Hospitals. Dr. McKenna has occupied several medical management positions at Advocate Health Care that span from 1988 to 2013. In addition to his most recent position there, he served as vice president, medical management, of Home Healthcare Division; vice president, clinical excellence and medical management, at Good Samaritan Hospital; and regional vice president for medical management, central region. Additional experience includes starting Midwest Digestive Disease Specialists, a successful gastroenterology group, of which Dr. McKenna remained a partner for 28 years. He has held medical education positions, too, including assistant dean for Chicago Medical School at Lutheran General Hospital and clinical assistant professor of medicine at Loyola University’s Stritch School of Medicine. Dr. McKenna earned his medical degree at Loyola University’s Stritch School of Medicine and completed an internship, residency and fellowship in conjunction with this same institution. He also holds a bachelor’s degree from Marquette University. With headquarters in Flint, McLaren is one of the largest health care providers in the state with a system that reaches more than half of Michigan residents through more than 200 locations, 17,400 employees and 21,000 network physicians. McLaren Health Care had net revenues of $2.5 billion in 2012 and has achieved double-digit growth each year since 1989. The nonprofit system includes medical centers in Bay City, Flint, Lapeer, Lansing, Mount Clemens, Mount Pleasant, Petoskey and Pontiac. Additional health care services are provided at McLaren Clarkston; McLaren Bay Special Care in Bay City; McLaren Orthopedic Hospital in Lansing; and McLaren Proton Therapy Center in Flint . McLaren Health Care also operates McLaren Medical Group, an employed physician network; McLaren Homecare Group, an award-winning home health, hospice and medical supplies provider; McLaren Health Plan, a licensed HMO offering benefit plans for commercial businesses and Medicaid recipients; and McLaren Cancer Institute, the largest cancer care network of its kind in the state. For more information, visit mclaren.org.
HAP Appoints Annette Marcath as CIO: Health Alliance Plan last week announced the appointment of Annette Marcath as Vice President, Information Technology and Chief Information Officer. Over the past year, Marcath led the successful installation of HAP’s new systems that will enhance HAP’s ability to connect with its customers and adapt rapidly to future market opportunities. The goal of the new systems is to provide an even higher level of personalized service and support, more efficient business processes and new self-service tools that will enhance the overall customer experience. In her new role, Marcath will lead the Information Technology department, consisting of IT Support Operations, Medical & Business Informatics, Technology & eBusiness Development, and the Testing Center of Excellence. Marcath began her health care career at SelectCare, where she managed the IT department business applications. She joined HAP in 2001 as a project manager, where she successfully led numerous critical corporate initiatives. In 2008, she was named director of Organizational Performance – a new department dedicated to business process improvement. She was promoted to associate vice president, Business Integration in 2011. A lifelong Michigan resident, Marcath holds a bachelor’s degree in finance from Walsh College of Accountancy and Business Administration and is a certified Project Management Professional. She is a member of PMI (Project Management Institute) and a recent graduate of the Leadership Macomb XIV program. HAP is a Michigan-based, nonprofit health plan that provides health coverage to more than 670,000 members and companies of all sizes. For more than 50 years, HAP has partnered with leading doctors and hospitals, employers and community organizations to enhance the health and well-being of the lives we touch. HAP offers a product portfolio with six distinct product lines: Group Insured Commercial, Individual, Medicare, Medicaid, Self-Funded and Network Leasing. HAP excels in delivering award-winning preventive services, disease management and wellness programs, and personalized customer service. The National Committee for Quality Assurance awarded HAP’s commercial HMO and HAP Senior Plus Excellent Accreditation. More at http://www.hap.org.
Genesis Genetics Selects Tony Gordon To Lead U.K. And U.S. Operations: Genesis Genetics, a provider of pre-implantation genetic diagnosis and screening based on Detroit’s east side, has selected Tony Gordon as lab director (U.K) and vice president (U.S.). As a registered clinical scientist in the U.K., Gordon will sign off on all patient reports and lead efforts to expand Genesis Genetics’ testing operations throughout that country. In his role as vice president, Gordon will oversee scientific development, sales and marketing, and provide consultations on cytogenetics to U.S. labs. He will also be instrumental in expanding reproductive health services throughout the organization by developing a global laboratory group to explore new technologies and diagnostic tests. Prior to his role at Genesis Genetics, Gordon worked at BlueGnome in the U.K. where he, in part with Genesis Genetics, led the development of 24sure-PGS (Preimplantation Genetic Screening), which has been shown to increase pregnancy rates and reduce miscarriages. He also contributed to the development and global uptake of the CytoChip, a postnatal cytogenetic mental retardation/development delay microarray test. Gordon received his Ph.D. from Nottingham University in the U.K., and completed seven years of post-doctoral work in molecular cytogenetics at the Institute for Cancer Research in Sutton, London. He has also authored numerous peer-reviewed scientific papers, articles and abstracts. Genesis Genetics, founded by world-renowned scientists largely responsible for discovering preimplantation genetic diagnosis as a clinical practice, provides PGD and laboratory services for in vitro fertilization centers across the country and throughout the world. Genesis Genetics has laboratories in Argentina, Brasil, Jordon, South Africa, Taiwan, United Kingdom, and the United States. For more information visit http://www.genesisgenetics.org.